[Comment] Immunotherapy: a new era in small-cell lung cancer

21:18 EDT 4 Oct 2019 | The Lancet

Lung cancer is the most frequently diagnosed cancer (11·6% of all cancer cases) and the leading cause of deaths due to cancer (18·4% of all cancer deaths).1 About 15% of all diagnosed lung cancers are small-cell lung cancer (SCLC) and up to 60–70% of these are extensive-stage SCLC (ES-SCLC) at initial diagnosis.2,3

Original Article: [Comment] Immunotherapy: a new era in small-cell lung cancer


More From BioPortfolio on "[Comment] Immunotherapy: a new era in small-cell lung cancer"

Quick Search

Relevant Topics

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...